PharmAbcine Inc.

KOSDAQ:A208340 Stock Report

Market Cap: ₩9.2b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

PharmAbcine Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

ByeongIk Kim

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure2yrs
CEO ownershipn/a
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates

Analysis Article • Jan 23

Take Care Before Diving Into The Deep End On PharmAbcine Inc. (KOSDAQ:208340)

With a price-to-sales (or "P/S") ratio of 0.9x PharmAbcine Inc. ( KOSDAQ:208340 ) may be sending very bullish signals...
Analysis Article • Mar 29

PharmAbcine (KOSDAQ:208340) Has Debt But No Earnings; Should You Worry?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analysis Article • Dec 14

Health Check: How Prudently Does PharmAbcine (KOSDAQ:208340) Use Debt?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

CEO

ByeongIk Kim

2yrs
Tenure

ByeongIk Kim serves as Chief Executive Officer of PharmAbcine Inc. since 2024.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/01/27 09:13
End of Day Share Price 2026/01/26 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

PharmAbcine Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.